Login:
Share:
Email Facebook Twitter

Add Scancell Holdings to quick picks

Scancell Holdings Share Price (SCLP)



Share Price Information for Scancell Holdings (SCLP)


Share Price: 33.25Bid: 32.50Ask: 34.00Change: 0.00 (0.00%)No Movement on Scancell Hldgs
Spread: 1.50Spread as %: 4.62%Open: 33.00High: 33.50Low: 33.00Yesterday’s Close: 33.25
InfoCFDs vs Share Trading - Download your Free Guide from LSE Markets
When trading CFDs, Forex, and Spread bets, it is possible to lose more than your initial deposit.


Scancell Holdings Plc Ord 0.1P

Scancell Holdings is listed in the FTSE AIM All-Share
Scancell Holdings is part of the Pharmaceuticals & Biotechnology sector




Intraday Scancell Holdings Share Chart


Intraday Scancell Holdings Share Price Chart


Share Price SpacerPrice
33.25

Share Price SpacerBid
32.50

Share Price SpacerAsk
34.00

Share Price SpacerChange
0%0.00

Share Price SpacerVolume
0

Share Price SpacerOpen
33.00

Share Price SpacerHigh
33.50

Share Price SpacerLow
33.00

Share Price SpacerClose
33.25

Share Price SpacerCurrency
GBX

3 Month Scancell Holdings Share Graph


3 Month Scancell Holdings Share Price Graph


Currency Issue Country Shares in Issue Market Capitalisation Market Size
GBX GB 224.95m £74.80m 15,000

52 Week High 51.25 52 Week High Date 4-JUL-2013
52 Week Low 22.50 52 Week Low Date 15-JUL-2013

# Trades Vol. Sold Vol. Bought PE Ratio Earnings Dividend Yield
0 0 0 -33.929 -0.98 0.00 0.00


London South East Users info for Scancell Holdings



Users who hold SCLP also hold: Red Rock, Europa Oil&gas, Sareum, Afc Energy, Range Res.


Date
Time
Trade Prc
Volume
Buy/Sell
Bid
Ask
Value
 

17-Apr-14
16:12:25
33.595
1,735
Buy* 
32.50
34.00
582.87
Trade Type:
Ordinary

17-Apr-14
16:08:21
32.9575
18,243
Sell* 
32.50
34.00
6,012
Trade Type:
Ordinary

17-Apr-14
12:55:03
33.625
1,000
Buy* 
32.50
34.00
336.25
Trade Type:
Ordinary


*Buys and Sells are calculated on the difference between the trade price and the current mid price. As such, they can occasionally be incorrect.

View more Scancell Holdings trades >>

Directors Deals for Scancell Holdings (SCLP)
Trade DateActionNotifierPriceCurrencyAmountHolding
10-Dec-13Notification of Holding
Trade Notifier Information for Scancell Holdings
Lindy Durrant held the position of CEO at Scancell Holdings at the time of this trade.
 Lindy Durrant
000
10-Dec-13Notification of Holding
Trade Notifier Information for Scancell Holdings
Richard Goodfellow held the position of Joint CEO at Scancell Holdings at the time of this trade.
 Richard Goodfellow
000
21-Oct-13Sell
Trade Notifier Information for Scancell Holdings
Lindy Durrant held the position of CEO at Scancell Holdings at the time of this trade.
 Lindy Durrant
30GBX100,0000
View more Scancell Holdings directors dealings >>

Date/Time
Author
Subject
Share Price
Opinion
Today 13:02
paraty
C7
33.25
Hold

What are you on about " PANIC", panic will be the day I dump my 660,000 holding. It's unbelievable how right everybody is on here. I find it incredible that no one saw the OO coming sold all their shares at 60p and bought back at 22p. It is incredible that Inanaco bought shares at 45p just before the OO I was under the impression he new the Company's strategy before they did.
Today 12:59
Puritas
What We've Signed Up For
33.25
Strong Buy

As a result of changes in Scancell's prospectus following last years financing round and open offer this is now what shareholders have signed up for: "The Board remains firmly committed to a trade sale at an optimal point where significant shareholder value has been created on both the ImmunoBody® and Moditope™ platforms." "Given the intention to both develop the ModitopeTM platform further and recruit additional patients into the SCIBI clinical trial, the Board expects that the timeframe for any potential exit will be extended from that which the Board had originally envisaged. However, the Board remains firmly committed to a trade sale at an optimal point where significant shareholder value has been created on both the ImmunoBody® and ModitopeTM platforms." "We remain committed to a trade sale of the Company and while we acknowledge this additional work may delay such plans, we believe it will ultimately result in a markedly improved return to shareholders" We can see from this that the board has now gained necessary permissions for its current strategy. So in that sense it has modified its original prospectus in keeping with company law. A case therefore could be made that Scancell, as from the acceptance of this offer in July, is no longer obligated to sell the company immediately following Phase 2 results at all. In other words the above statements about its intended trade sale and their acceptance by shareholders have provided Scancell with a certain amount of added flexibility on timing.
Today 12:39
CHELSEA7
Paraty
33.25
Strong Buy

There would appear to be a situation here that if a poster changes his opinions based on further research and other market indicators to suggest another course of statagy could be more fruitful they are immediately jumped on for saying so. Once again it is you, going as far as suggesting they could be sued. Well cannot think of any company private or public which by being accountable to shareholders or staff alike that does not change stratagy when trading conditions need to be resolved for the better. In much the same way that us PIs change our targets accordingly. I have said this may times changing how shareholders can achieve true value is not reason to take your view-sue!!!!!! Whatever deal you have done that causes you to panic so frequently is contrary to how the vast majority here see it. I refer to my 21.34 last night and am surprised you still choose to do exactly the same within 12 hours over how Puritas sees it and not even confirmed by Scancell that it has even been debated. Perhaps if you are going to carry on posting in this way you might annoy less people by explaining the full story AIMHO
Today 11:37
Puritas
Scancell Under The Hammer
33.25
Strong Buy

Having said all that I personally feel it would be a good idea for the company to consider further options. But to do this it would likely have to seek shareholder approval. In its most recent statements, for instance to the Wall Street Journal in December, Scancell has insisted that "it is still aiming to sell the business at the earliest opportunity but will also consider revenue-generating deals in order to enhance the value of the company when it is eventually sold." So the directors are still focused on seeking a buyer. But if the company starts to make money from out-licensing Moditope many investors might wish Scancell would consider other options to selling the business outright. Scancell could become self financing and successfully cash generating from out-licensing Moditope vaccines and the possibility then presents itself of Scancell's share price being driven forward on that basis. This could ultimately lead to a higher share price than if the company was sold early or make shareholders feel that better returns might be achievable if Scancell goes it alone.
Today 11:03
Puritas
Paraty
33.25
Strong Buy

What I said was that the board had an obligation under company law to sell the company following Phase 2. They said they expected to sell following Phase 2 trials of their SCIB1 vaccine. These trials are still ongoing and have been extended to include a higher dose of the vaccine in patients with tumour load. It is generally accepted that if a company states an intention of this kind it is obligated to fulfill it at some point otherwise it opens itself up to investors making compensation claims on the basis of trading under a false prospectus. So far, because of the extension of Phase 2 at the 8mg dose they are still able to meet these obligations. The first patient in the extended Phase 2 was treated last month. There are up to 12 more patients to be treated. This will be done at intervals as recruitment allows. Each patient's course of treatment is carried out over a period of 6 months. The results of the trial will be published around 6 months following the final patient having received all their jabs. Its difficult to say when the results from this tumour trial will be available. Possibly before the end of 2015 I would think.
Today 10:36
paraty
Puritas 21:24
33.25
Hold

That is the most ridiculous message I have read on this Board in nigh on 2 years and I won't even go to the trouble of explaining why. The first sentence says it all, what an absolute load of carp, it was a year ago you were telling everybody the Board were legally bound to sell the Company after the phase 2 results as they had stated !!!!

Share prices shown are taken at time of message posting.
NEWThread ViewThread View
View more share chat for Scancell Holdings (SCLP) >>
Please Login or Register to post messages

Share Trading BrochureRequest your Free brochures on share dealing, spread betting and CFDs




Sign up for Live Prices


CD02WL.001.081313


Datafeed and UK data supplied by NBTrader and Digital Look. While London South East do their best to maintain the high quality of the information displayed on this site,
we cannot be held responsible for any loss due to incorrect information found here. All information is provided free of charge, 'as-is', and you use it at your own risk.
The contents of all 'Chat' messages should not be construed as advice and represent the opinions of the authors, not those of London South East Limited, or its affiliates.
London South East does not authorise or approve this content, and reserves the right to remove items at its discretion.